HomeNewsBusinessHere's why ad volumes in January, February in 2021 were the highest since 2017

Here's why ad volumes in January, February in 2021 were the highest since 2017

According to Karan Taurani, Vice-President, Elara Capital, contribution from sports, new channels that launched in the last few months are some of the reasons that led to the growth in ad volumes.

April 01, 2021 / 21:05 IST
Story continues below Advertisement
While there is an expectation of a strong ad revenue growth in the second half of FY22, there could be some challenges the broadcasters would have to face. (Representative image)
While there is an expectation of a strong ad revenue growth in the second half of FY22, there could be some challenges the broadcasters would have to face. (Representative image)

In January and February of this year, something interesting happened in the TV advertising space. Ad volumes hit an all-time high since 2017, according to Broadcast Audience Research Council India (BARC) data.

But what led to this growth?

Story continues below Advertisement

According to Karan Taurani, Vice-President, Elara Capital, contribution from sports, new channels that launched in the last few months are some of the reasons that led to the growth in ad volumes.

"Many sporting events were delayed due to coronavirus which happened on a back to back basis this year. So, that was one reason. Plus, after BARC blackout, news channels have increased inventory because they are suffering in terms of pricing," he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show